• Therapeutic Cataract & Refractive
  • Lens Technology
  • Glasses
  • Ptosis
  • Comprehensive Eye Exams
  • AMD
  • COVID-19
  • DME
  • Ocular Surface Disease
  • Optic Relief
  • Geographic Atrophy
  • Cornea
  • Conjunctivitis
  • LASIK
  • Myopia
  • Presbyopia
  • Allergy
  • Nutrition
  • Pediatrics
  • Retina
  • Cataract
  • Contact Lenses
  • Lid and Lash
  • Dry Eye
  • Glaucoma
  • Refractive Surgery
  • Comanagement
  • Blepharitis
  • OCT
  • Patient Care
  • Diabetic Eye Disease
  • Technology

AAOpt 2023: The perfect presbyopic patient

News
Article

Post-hoc data helps shine light on better understanding what patient demographics are best suited for presbyopia drops.

Jade Coats, OD, caught up with Optometry Times®' during the 2023 American Academy of Optometry meeting in New Orleans to share a brief overview of a presbyopia poster she was presenting.

Editor's note: This transcript has been lightly edited for clarity.

Jade Coats, OD:

My name is Jade Coats. I'm an optometrist practicing in Northwest Arkansas at McDonald Eye Associates.

At Academy here in New Orleans this week I plan to present on behalf of Orasis regarding some really interesting poster information, some post-hoc data that actually is really helping us understand better the perfect demographics for the presbyopia drops.

Some key takeaways are that surprisingly, but also not surprisingly, there might be a perfect person. And clinically speaking, we know that evaluating the best-corrected distance near acuity is really going to be an important factor in determining who's the best patient for this presbyopia drop.

The next step for this research would be to launch the product and obviously to get our hands on it, get it into the clinics, get it into the patient's hands and have them try it.

Presbyopia has been around; it's not going anywhere. It affects every human blessed to have enough birthdays and so now we have an alternative treatment option and it's just really exciting times but that has to do with pharmaceuticals.

Related Videos
Deborah Ferrington details a session on mitochondrial maintenance and retinal health in patients with AMD at ARVO 2024
Andrew Pucker, OD, PhD
Marjorie Rah, OD, PhD, FAAO
Selina McGee, OD, FAAO
Melissa Tawa, OD, FAAO
Marc Bloomenstein, OD's Insights from CIME on Diagnosing and Treating Demodex Blepharitis
Jessica Steen, OD, FAAO, discusses systemic medication and ocular adverse effects at Vision Expo East 2024
The Vision Council CEO Ashley Mills gives a preview of the 2024 Vision Expo East event
Barry Eiden, OD, FAAO, FSLS, chats with Optometry Times about the 2024 IKA Symposium
© 2024 MJH Life Sciences

All rights reserved.